Abstract
Background
The association between body mass index (BMI) and lung cancer is still disputed because of possible residual confounding by smoking and preclinical weight loss in case–control studies. We examined this association using data from the multicenter ICARE study in France, a large, population-based case–control study.
Methods
A total of 2,625 incident lung cancer cases and 3,381 controls were included. Weight was collected at interview, 2 years before the interview, and at age 30. Lifetime smoking exposure was calculated using the comprehensive smoking index (CSI). Adjusted odds ratios (aORs) and 95 % confidence intervals were estimated by unconditional logistic regression and controlled for age, area, education, CSI, occupational exposure, previous chronic bronchitis, and parental history of lung cancer. We also examined the role of weight change. Analyses were stratified by smoking status and sex.
Results
When compared with that of men with normal BMI 2 years before the interview, lung cancer aORs (95 % CI) among men with BMIs of <18.5, 25–29.9, 30–32.4, and ≥32.5 kg/m² were 2.7 (95 % CI 1.2–6.2), 0.9 (95 % CI 0.7–1.1), 0.8 (95 % CI 0.6–1.1), and 0.8 (95 % CI 0.6–1.0), respectively (p trend = 0.02). Results were more pronounced among current smokers and were similar in men and women. Weight gain over time was associated with a significant decreased risk of lung cancer.
Conclusions
We found an inverse dose-dependent association between lung cancer risk and BMI 2 years prior to interview in current smokers.
Impact statement
BMI might be an individual factor impacting the risk of lung cancer related to smoking’s carcinogen-induced DNA damage.
Similar content being viewed by others
Notes
France is divided into 96 administrative units called départements.
References
WHO (2008) GLOBOCAN. Cancer incidence and mortality worldwide in 2008. http://globocan.iarc.fr/
Devesa SS, Bray F, Vizcaino AP, Parkin DM (2005) International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 117(2):294–299
Alberg AJ, Ford JG, Samet JM (2007) Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines. Chest 132(3 Suppl):29S–55S
Koshiol J, Rotunno M, Consonni D, Pesatori AC, De Matteis S, Goldstein AM et al (2009) Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One 4(10):e7380
Schwartz AG, Cote ML, Wenzlaff AS, Van Dyke A, Chen W, Ruckdeschel JC et al (2009) Chronic obstructive lung diseases and risk of non-small cell lung cancer in women. J Thorac Oncol 4(3):291–299
Wasswa-Kintu S, Gan WQ, Man SF, Pare PD, Sin DD (2005) Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 60(7):570–575
Alavanja MC, Brownson RC, Boice JD Jr, Hock E (1992) Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol 136(6):623–632
Rodriguez-Roisin R, Soriano JB (2008) Chronic obstructive pulmonary disease with lung cancer and/or cardiovascular disease. Proc Am Thorac Soc 5(8):842–847
Tyczynski JE, Bray F, Parkin DM (2003) Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. Lancet Oncol 4(1):45–55
Brenner AV, Wang Z, Kleinerman RA, Wang L, Zhang S, Metayer C et al (2001) Previous pulmonary diseases and risk of lung cancer in Gansu Province, China. Int J Epidemiol 30(1):118–124
Pairon JC, Brochard P, Le Bourgeois JP, Ruffié P (eds) (2000) Les cancers professionnels. Editions Margaux Orange, Paris, France
WHO/FAO (2003) Diet, nutrition and the prevention of chronic disease. In: WHO technical reports series 916. Report of a Joint WHO/FAO Expert Consultation, Geneva
Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579–591
Ursin G, Longnecker MP, Haile RW, Greenland S (1995) A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 6(2):137–141
Smith M, Zhou M, Whitlock G, Yang G, Offer A, Hui G et al (2008) Esophageal cancer and body mass index: results from a prospective study of 220,000 men in China and a meta-analysis of published studies. Int J Cancer 122(7):1604–1610
Kabat GC, Chang CJ, Wynder EL (1994) The role of tobacco, alcohol use, and body mass index in oral and pharyngeal cancer. Int J Epidemiol 23(6):1137–1144
Franceschi S, Dal Maso L, Levi F, Conti E, Talamini R, La Vecchia C (2001) Leanness as early marker of cancer of the oral cavity and pharynx. Ann Oncol 12(3):331–336
Andreotti G, Hou L, Beane Freeman LE, Mahajan R, Koutros S, Coble J et al (2010) Body mass index, agricultural pesticide use, and cancer incidence in the Agricultural Health Study cohort. Cancer Causes Control 21(11):1759–1775
Chyou PH, Nomura AM, Stemmermann GN (1994) A prospective study of weight, body mass index and other anthropometric measurements in relation to site-specific cancers. Int J Cancer 57(3):313–317
Drinkard CR, Sellers TA, Potter JD, Zheng W, Bostick RM, Nelson CL et al (1995) Association of body mass index and body fat distribution with risk of lung cancer in older women. Am J Epidemiol 142(6):600–607
Goodman MT, Wilkens LR (1993) Relation of body size and the risk of lung cancer. Nutr Cancer 20(2):179–186
Kabat GC, Kim M, Hunt JR, Chlebowski RT, Rohan TE (2008) Body mass index and waist circumference in relation to lung cancer risk in the women’s health initiative. Am J Epidemiol 168(2):158–169
Kabat GC, Miller AB, Rohan TE (2007) Body mass index and lung cancer risk in women. Epidemiology 18(5):607–612
Kabat GC, Wynder EL (1992) Body mass index and lung cancer risk. Am J Epidemiol 135(7):769–774
Kanashiki M, Sairenchi T, Saito Y, Ishikawa H, Satoh H, Sekizawa K (2005) Body mass index and lung cancer: a case-control study of subjects participating in a mass-screening program. Chest 128(3):1490–1496
Kark JD, Yaari S, Rasooly I, Goldbourt U (1995) Are lean smokers at increased risk of lung cancer? The Israel Civil Servant Cancer Study. Arch Intern Med 155(22):2409–2416
Knekt P, Heliovaara M, Rissanen A, Aromaa A, Seppanen R, Teppo L et al (1991) Leanness and lung-cancer risk. Int J Cancer 49(2):208–213
Koh WP, Yuan JM, Wang R, Lee HP, Yu MC (2010) Body mass index and smoking-related lung cancer risk in the Singapore Chinese Health Study. Br J Cancer 102(3):610–614
Kollarova H, Machova L, Horakova D, Cizek L, Janoutova G, Janout V (2008) Is obesity a preventive factor for lung cancer? Neoplasma 55(1):71–73
Kubik A, Zatloukal P, Boyle P, Robertson C, Gandini S, Tomasek L et al (2001) A case-control study of lung cancer among Czech women. Lung Cancer 31(2–3):111–122
Kubik AK, Zatloukal P, Tomasek L, Pauk N, Havel L, Krepela E et al (2004) Dietary habits and lung cancer risk among non-smoking women. Eur J Cancer Prev 13(6):471–480
Olson JE, Yang P, Schmitz K, Vierkant RA, Cerhan JR, Sellers TA (2002) Differential association of body mass index and fat distribution with three major histologic types of lung cancer: evidence from a cohort of older women. Am J Epidemiol 156(7):606–615
Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, Tryggvadottir L (1997) Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 6(11):863–873
Rauscher GH, Mayne ST, Janerich DT (2000) Relation between body mass index and lung cancer risk in men and women never and former smokers. Am J Epidemiol 152(6):506–513
Chiolero A, Faeh D, Paccaud F, Cornuz J (2008) Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 87(4):801–809
Hamilton W, Peters TJ, Round A, Sharp D (2005) What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study. Thorax 60(12):1059–1065
Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR et al (2007) Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer 15(1):39–46
Buccheri G, Ferrigno D (2004) Lung cancer: clinical presentation and specialist referral time. Eur Respir J 24(6):898–904
Corner J, Hopkinson J, Fitzsimmons D, Barclay S, Muers M (2005) Is late diagnosis of lung cancer inevitable? Interview study of patients’ recollections of symptoms before diagnosis. Thorax 60(4):314–319
Luce D, Stucker I (2011) Investigation of occupational and environmental causes of respiratory cancers (ICARE): a multicenter, population-based case-control study in France. BMC Public Health 11:928
WHO (World Health Organization) (2000) International classification of diseases for oncology, 3rd edn. WHO, Geneva
Rothman KJ, Greenland S (2008) Modern epidemiology, 3rd edn. Lippincott Williams and Wilkins, Philadelphia
WHO-IARC (2007) IARC monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses, vol 90. WHO-IARC, Lyon, France
WHO-IARC (2012) IARC monographs on the evaluation of carcinogenic risks to humans. Chemical agents and related occupations, vol 100. WHO-IARC, Lyon, France
Consonni D, De Matteis S, Lubin JH, Wacholder S, Tucker M, Pesatori AC et al (2010) Lung cancer and occupation in a population-based case-control study. Am J Epidemiol 171(3):323–333
Ahrens W, Merletti F (1998) A standard tool for the analysis of occupational lung cancer in epidemiologic studies. Int J Occup Environ Health 4(4):236–240
WHO (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO technical report series 894. World Health Organization, Geneva
WHO Global database on body mass index. http://apps.who.int/bmi/index.jsp?introPage=intro_3.html
Leffondre K, Abrahamowicz M, Xiao Y, Siemiatycki J (2006) Modelling smoking history using a comprehensive smoking index: application to lung cancer. Stat Med 25(24):4132–4146
Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E et al (2011) COPD in never-smokers: results from the population-based burden of obstructive lung disease study. Chest 139(4):752–763
Mannino DM, Buist AS (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370(9589):765–773
Mandrekar SJ, Schild SE, Hillman SL, Allen KL, Marks RS, Mailliard JA et al (2006) A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials. Cancer 107(4):781–792
Stommel M, Schoenborn CA (2009) Accuracy and usefulness of BMI measures based on self-reported weight and height: findings from the NHANES and NHIS 2001–2006. BMC Public Health 9:421
Unité de surveillance et d’épidémiologie nutritionnelle (Usen) (2007) Étude nationale nutrition santé (ENNS 2006)—situation nutritionnelle en France en 2006 selon les indicateurs d’objectif et les repères du Programme national nutrition santé (PNNS). Institut de veille sanitaire, Université de Paris 13, Conservatoire national des arts et métiers
Ichiba M, Yamada S, Ishii K, Gonda K, Murai R, Shimomura T et al (2007) Significance of urinary excretion of 8-hydroxy-2′-deoxyguanosine in healthy subjects and liver disease patients. Hepatogastroenterology 54(78):1736–1740
Kasai H, Iwamoto-Tanaka N, Miyamoto T, Kawanami K, Kawanami S, Kido R et al (2001) Life style and urinary 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage: effects of exercise, working conditions, meat intake, body mass index, and smoking. Jpn J Cancer Res 92(1):9–15
Loft S, Vistisen K, Ewertz M, Tjonneland A, Overvad K, Poulsen HE (1992) Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 13(12):2241–2247
Mizoue T, Kasai H, Kubo T, Tokunaga S (2006) Leanness, smoking, and enhanced oxidative DNA damage. Cancer Epidemiol Biomarkers Prev 15(3):582–585
Pilger A, Germadnik D, Riedel K, Meger-Kossien I, Scherer G, Rudiger HW (2001) Longitudinal study of urinary 8-hydroxy-2′-deoxyguanosine excretion in healthy adults. Free Radic Res 35(3):273–280
Pilger A, Rudiger HW (2006) 8-hydroxy-2′-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures. Int Arch Occup Environ Health 80(1):1–15
Sakano N, Wang DH, Takahashi N, Wang B, Sauriasari R, Kanbara S et al (2009) Oxidative stress biomarkers and lifestyles in Japanese healthy people. J Clin Biochem Nutr 44(2):185–195
Tamae K, Kawai K, Yamasaki S, Kawanami K, Ikeda M, Takahashi K et al (2009) Effect of age, smoking and other lifestyle factors on urinary 7-methylguanine and 8-hydroxydeoxyguanosine. Cancer Sci 100(4):715–721
Yano T, Shoji F, Baba H, Koga T, Shiraishi T, Orita H et al (2009) Significance of the urinary 8-OHdG level as an oxidative stress marker in lung cancer patients. Lung Cancer 63(1):111–114
Godschalk RW, Feldker DE, Borm PJ, Wouters EF, van Schooten FJ (2002) Body mass index modulates aromatic DNA adduct levels and their persistence in smokers. Cancer Epidemiol Biomarkers Prev 11(8):790–793
Palli D, Vineis P, Russo A, Berrino F, Krogh V, Masala G et al (2000) Diet, metabolic polymorphisms and DNA adducts: the EPIC-Italy cross-sectional study. Int J Cancer 87(3):444–451
Rundle A, Madsen A, Orjuela M, Mooney L, Tang D, Kim M et al (2007) The association between benzo[a]pyrene-DNA adducts and body mass index, calorie intake and physical activity. Biomarkers 12(2):123–132
Peluso M, Airoldi L, Munnia A, Colombi A, Veglia F, Autrup H et al (2008) Bulky DNA adducts, 4-aminobiphenyl-haemoglobin adducts and diet in the European prospective investigation into cancer and nutrition (EPIC) prospective study. Br J Nutr 100(3):489–495
Acknowledgments
The authors thank American Journal Experts for their editorial assistance. This work was supported by the French agency of health security (ANSES); the Fondation de France; the French National Research Agency (ANR); the National Institute of Cancer (INCA); the Foundation for Medical Research (FRM); The French Institute for Public Health Surveillance (InVS); The Health Ministry (DGS); the Organization for the Research on Cancer (ARC); and the French Ministry of work, solidarity and public function (DGT).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tarnaud, C., Guida, F., Papadopoulos, A. et al. Body mass index and lung cancer risk: results from the ICARE study, a large, population-based case–control study. Cancer Causes Control 23, 1113–1126 (2012). https://doi.org/10.1007/s10552-012-9980-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-012-9980-3